Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

Diagnosed with mild cognitive impairment (MCI) in 2018, Mr Almond, from Esher, took part in two 18-month trials for donanemab ...

Donanemab, the most effective treatment yet for the disease, has been banned on the health service despite regulators ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

If I were a statistician tucked away in an NHS backroom, I might well curse the day the health service was founded. There, on ...

NICE has said the Alzheimer's disease drug is too expensive to be available on the NHS, but researchers are now hoping to ...

Health spending watchdog said costs could not justify benefits after treatment slowed cognitive decline by around four to ...

Despite the drug – known as donanemab - being found to stall the deadly condition, its impact was not deemed worth the cost.

UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...

Ruth Langsford said she doesn't fear ageing following her split from Eamonn Holmes and hopes to remain active in the years to ...